51 press releases
Supporting people with type 2 diabetes throughout the pandemic
January 14, 2021
When the pandemic forced gyms to close, it caused some disruption to the plans that had been developed for patients by the team at the Montreal Heart Institute’s Diabetes Prevention Clinic sponsored by Sun Life. As people with type 2 diabetes are more vulnerable when it comes to COVID-19, it was important they remained safe at home. Fortunately, when public health restrictions were implemented, telehealth was there to make remote monitoring possible.
Montreal Auto Show Charity Preview : A new formula for the 17th edition!
January 4, 2021
Starting January 23rd, join us for the 17th virtual edition of the Montreal Auto Show Charity Preview.
New data supports development of colchicine for the prevention of acute respiratory distress syndrome
December 3, 2020
The Montreal Heart Institute has announced that colchicine, a widely available low-cost drug, reduces acute lung injury, acute respiratory distress syndrome and respiratory failure in pre-clinical models. The article reporting these results was published yesterday by the Public Library of Science ONE (PLOS ONE).
Colchicine shows promise as a treatment for at-home COVID-19 patients
November 28, 2020
The Montreal Heart Institute today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as recommended by the independent data monitoring committee (DMC), following a second interim analysis.
National Philanthropy Day – The Montreal Heart Institute Foundation honours Sophie Desmarais
November 16, 2020
As part of National Philanthropy Day, the Montreal Heart Institute Foundation is highlighting the invaluable support of Ms. Sophie Desmarais. This great philanthropist, who for many years has been close to the cause of heart diseases, stood out this year for her involvement in the Colcorona clinical trial aimed to confirm the potential of colchicine to fight COVID-19.
Twice as generous thanks to Manulife
November 11, 2020
With the holiday season just around the corner, we’re proud to count on Manulife to give your generosity an even greater impact. Until December 31st, 2020, every donation will be matched by Manulife. This support allows the Institute to finance major discoveries and help its professionals treat more than 68,000 patients every year.
Common hormone could provide the answer to treating atrial fibrillation
November 5, 2020
New research published today in Nature shows that calcitonin, a well-recognized thyroid hormone that helps regulate bone mass and collagen production, is also produced by cells in the heart. This discovery could hold the key to developing new treatments for people with atrial fibrillation (AF), a common and quite problematic heart rhythm disorder.
CQDM funds the development of a novel artificial intelligence tool for cardiovascular clinical trials
November 5, 2020
The CQDM is pleased to announce the launch of a $600,000 collaborative project in biopharma and artificial intelligence (AI) to develop an AI-driven precision medicine tool.
The Montreal Heart Institute stands out at the prestigious European Society of Cardiology congress
August 31, 2020
During the prestigious virtual congress of the European Society of Cardiology (ESC), researchers from the Montreal Heart Institute presented recent data regarding the impact of colchicine on cardiovascular disease.
Sun Life supports Colcorona genetic study
August 26, 2020
Thank you to Sun Life for contributing to the funding of the Montreal Heart Institute's Colcorona genetic sub-study led by Dr. Marie-Pierre Dubé. This study will help to better prevent the complications of COVID-19 by helping to better target effective medical interventions in patients with the disease.